Device Trial Radar · NCT05424354
Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing
Last checked: Nov 20, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
May 26, 2022
Primary completion
Jun 30, 2026
Study completion Sep 30, 2026
Sponsor
- Lead sponsor
- ULURU Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Navy Advanced Medical Development (NAMD) Command
- First posted
- Jun 21, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 72 hours prior to enrollment in the study) partial thickness burn wound, less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed for up to 28 days after enrollment.
Conditions
- Wounds and Injuries
Interventions
Altrazeal (R) Transforming Powder DressingDevice
After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with Altrazeal TPD.
Standard of Care burn dressingOther
After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with the institution's standard of care burn dressing.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain from the Burn WoundTime frame: 28 days (or sooner if the wound heals prior to 28 days)
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
University of California-Irvine
Orange, California · Recruiting
MedStar Washington Hospital Center
Washington D.C., District of Columbia · Recruiting
Jackson Memorial Hospital UM/JMH Burn Center
Miami, Florida · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.